There was a lower probability of initiating psycholeptics and having postpartum psychiatric emergencies in the early discontinuer and late discontinuer groups compared to the continuers.
New research from Scandinavia suggest pregnant women treated with antidepressants do benefit more from the continued use of the treatment.1
A team, led by Nhung T. H. Trinh, PhD, PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, investigated the associations between longitudinal antidepressant fill trajectories during pregnancy and postpartum psychiatric outcomes.
Approximately half of women treated for affective disorders discontinue antidepressant use during pregnancy, but this discontinuation treatment during pregnancy could be beneficial.
“The treatment of pregnant women with antidepressants must balance possible risks of untreated mental disorders against fetal drug exposure,” the authors wrote. “While psychiatric disorders before and during pregnancy are known to be associated with postpartum mental health, few studies have addressed how antidepressant use before and during pregnancy influences postpartum psychiatric outcomes.”
In the cohort study, the investigators nationwide registers in Denmark and Norway involving 41,475 live-born singleton pregnancies in Denmark between 1997-2016 and 16,459 live-born singleton pregnancies in Norway between 2009-2018 for women who filled at least 1 antidepressant prescription within 6 months prior to pregnancy.
The team obtained data on antidepressant prescription fills from the prescription registers and modeled antidepressant treatment during pregnancy using the k-means longitudinal method.
The investigators sought main outcomes of the initiation of psycholeptics, psychiatric emergencies, or records of self-harm within 1 year post-partum.
The maternal age was 30.7 years in Denmark and 29.9 years in Norway.
The results identified 4 clear antidepressant trajectories. There were early discontinuers (31.3% and 30.4% of the included pregnancies in Denmark and Norway, respectively), late discontinuers (previously stable users) (21.5% and 27.8%), late discontinuers (short-term users) (15.9% and 18.4%), and continuers (31.3% and 23.4%).
There was a lower probability of initiating psycholeptics and having postpartum psychiatric emergencies in the early discontinuer and late discontinuer groups compared to the continuers.
There was also an increase, albeit moderate, in the probability of initiating of psycholeptics in the group of late discontinuers compared to continuers (hazard ratios [HR], 1.13; 95% confidence interval [CI], 1.03-1.24), which was more pronounced among women with previous affective disorders (HR, 1.28; 95% CI, 1.12-1.46).
Finally, no association was found between antidepressant fill trajectories and postpartum self-harm.
“Based on pooled data from Denmark and Norway, a moderately elevated probability of initiation of psycholeptics in late discontinuers (previously stable users) vs continuers was found,” the authors wrote. “These findings suggest that women with severe mental illness who are currently on stable treatment may benefit from continuing antidepressant treatment and personalized treatment counseling during pregnancy.”
Reference
Trinh NTH, Munk-Olsen T, Wray NR, et al. Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway. JAMA Psychiatry. Published online March 08, 2023. doi:10.1001/jamapsychiatry.2023.0041
This article was initially published by our sister publication HCP Live.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Reduced therapy attendance near childbirth reported among US military service members
May 30th 2024A study found a significant decline in mental health therapy sessions among US military parents during the months surrounding childbirth, highlighting the need for more accessible treatment options.
Read More
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More
Major adverse pregnancy outcomes linked to long-term risk of kidney disease
May 28th 2024A recent study highlighted the significant association between adverse pregnancy outcomes and an elevated long-term risk of chronic kidney disease, emphasizing the need for heightened awareness and monitoring.
Read More